Understanding ROHHAD Syndrome: A Guide for Parents and Caregivers
At a Glance
ROHHAD is an ultra-rare childhood syndrome marked by sudden weight gain, hypothalamic dysfunction, sleep-related hypoventilation, and autonomic changes. It has no confirmed gene or single diagnostic test, so doctors combine the symptom pattern with genetic, hormone, sleep, and imaging evaluations.
Receiving a diagnosis of ROHHAD syndrome can feel overwhelming, especially because it is an ultra-rare condition that most people—including many medical professionals—have never heard of. You are likely here after a long and exhausting “diagnostic odyssey,” searching for answers to why your previously healthy child suddenly began facing complex health challenges [1]. This page is designed to help you understand the basics of this condition and why the road to a diagnosis can be so complicated, while keeping in mind that recommendations vary by your child’s findings and this guide does not replace the treating team’s instructions.
What is ROHHAD?
ROHHAD is an acronym where each letter represents a core part of the syndrome [1][2]:
- Rapid-onset Obesity: The first sign is typically a sudden, dramatic increase in weight over a very short period that deviates rapidly from the child’s growth curve [3].
- Hypothalamic dysfunction: The hypothalamus is the part of the brain that acts as a control center for many body functions. When it malfunctions, it can cause issues with water balance (thirst), growth, puberty, and thyroid function [1][4].
- Hypoventilation: This refers to shallow or slow breathing, particularly during sleep, which can lead to low oxygen and high carbon dioxide (hypercapnia) levels [3][5].
- Autonomic Dysregulation: The autonomic nervous system controls involuntary functions like heart rate, body temperature, sweating, and pain perception. Problems here might look like unusual sweating patterns or a reduced sensitivity to pain [1][6].
In some cases, the acronym is expanded to ROHHAD-NET, where NET stands for neural crest tumors. These are tumors, such as ganglioneuromas, that are found in approximately 40-56% of children with this syndrome [3][4].
An Ultra-Rare Journey
ROHHAD is exceptionally rare. There are historically fewer than 200 known cases documented in medical literature worldwide, though case counts are incomplete and quickly become outdated [1][4]. Because it is so rare, there are no “standard” population statistics, and many doctors may only ever see one case in their entire career.
One of the most defining characteristics of ROHHAD is that the child is typically healthy and meets all developmental milestones during their first year of life [2][7]. Symptoms usually begin to appear between the ages of 1.5 and 7 years, with a median onset around age 4 [3][8]. The suddenness of the weight gain is often the first clue, though the four features may not appear in a fixed order and not every child develops all of them.
The Search for a Cause
As a parent, your first question is likely “why did this happen?” It is important to know that, currently, there is no established causative gene for ROHHAD [1][9].
Extensive research, including sequencing the entire genomes of affected children, has not found a single shared diagnostic “ROHHAD gene” [10][11]. This distinguishes ROHHAD from other conditions that might look similar, such as Prader-Willi Syndrome or Congenital Central Hypoventilation Syndrome (CCHS), both of which have clear genetic markers [2][7].
The leading scientific theories currently focus on two possibilities:
- Immune-Mediated Process: Some researchers believe the body’s immune system may mistakenly attack the hypothalamus [4][12].
- Paraneoplastic Syndrome: In children who have a neural crest tumor, the body may produce antibodies to fight the tumor that then accidentally damage the nervous system [12][13].
Research into an investigational marker called anti-ZSCAN1 antibodies is ongoing, as these have been found in the blood or spinal fluid of some children with ROHHAD in small, preliminary studies (around 70-85% in select cohorts), but it is not a validated routine diagnostic test and does not replace imaging [12][13].
How is ROHHAD Diagnosed?
Because there is no “ROHHAD gene” and no single blood test can confirm it, ROHHAD is what doctors call a clinical diagnosis [1]. This means the diagnosis is made by looking at the whole picture of your child’s symptoms over time.
Doctors must “rule out” other conditions first. This often involves:
- Genetic testing to rule out PHOX2B variants (linked to CCHS) or Prader-Willi Syndrome [2][5].
- Hormone testing to evaluate the health of the hypothalamus and pituitary glands [1].
- Sleep studies (polysomnography) to monitor for breathing changes [14][6].
- Imaging (like MRI or CT scans) to look for small neural crest tumors in the chest or abdomen [3].
This process can be frustrating because it requires time and observation to see how the syndrome “unfolds” [4]. While the weight gain happens quickly, other symptoms like breathing issues or autonomic changes may not appear for months or even years afterward [3][8]. Diagnosis is a journey of careful, multidisciplinary monitoring by a team of specialists.
Common questions in this guide
What are the earliest signs of ROHHAD, and when do they usually start?
What does a ROHHAD diagnosis involve if there is no single test?
Is ROHHAD inherited, and what causes it?
What does ROHHAD-NET mean, and why are scans needed?
Can anti-ZSCAN1 antibodies confirm ROHHAD?
How are breathing and hormone problems monitored in a child with suspected ROHHAD?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About testing
Which genetic, hormone, or sleep tests would be used to rule out other conditions?
Related conditions
Could a PHOX2B gene test help rule out CCHS?
Causes and research
What research is being done into what causes ROHHAD?
Get notified when new evidence is published on Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
The Enigma That Is ROHHAD Syndrome: Challenges and Future Strategies.
Hawton K, Giri D, Crowne E, et al.
Brain sciences 2024; (14(11)) doi:10.3390/brainsci14111046.
PMID: 39595809 - 2
Developmental disorders affecting the respiratory system: CCHS and ROHHAD.
Ceccherini I, Kurek KC, Weese-Mayer DE
Handbook of clinical neurology 2022; (189()):53-91 doi:10.1016/B978-0-323-91532-8.00005-7.
PMID: 36031316 - 3
ROHHAD(NET) Syndrome: Systematic Review of the Clinical Timeline and Recommendations for Diagnosis and Prognosis.
Harvengt J, Gernay C, Mastouri M, et al.
The Journal of clinical endocrinology and metabolism 2020; (105(7)) doi:10.1210/clinem/dgaa247.
PMID: 32407531 - 4
Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD): a collaborative review of the current understanding.
Khaytin I, Victor AK, Barclay SF, et al.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2023; (33(3)):251-268 doi:10.1007/s10286-023-00936-y.
PMID: 37162653 - 5
Case Report: Considerations of nocturnal ventilator support in ROHHAD syndrome in chronic care of childhood central hypoventilation with hypothalamus dysfunction.
Zhao R, Dong X, Gao Z, Han F
Frontiers in pediatrics 2022; (10()):919921 doi:10.3389/fped.2022.919921.
PMID: 36120657 - 6
Novel autonomic dysregulation score in children with hypothalamic syndrome.
Doelman-Oldenburger NJ, Müller HL, van Santen HM
Endocrine connections 2025; (14(12)).
PMID: 41251290 - 7
ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison.
Barclay SF, Rand CM, Nguyen L, et al.
Orphanet journal of rare diseases 2018; (13(1)):124 doi:10.1186/s13023-018-0860-0.
PMID: 30029683 - 8
Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine Tumors (ROHHADNET) Syndrome: A Systematic Review.
Lee JM, Shin J, Kim S, et al.
BioMed research international 2018; (2018()):1250721 doi:10.1155/2018/1250721.
PMID: 30584530 - 9
Genetic evaluation of five patients with ROHHAD-NET using whole genome sequencing and optical genome mapping.
van Engelen N, van Santen HM, van Dijk F, et al.
Orphanet journal of rare diseases 2025; (20(1)):412 doi:10.1186/s13023-025-03938-3.
PMID: 40775360 - 10
Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD): exome sequencing of trios, monozygotic twins and tumours.
Barclay SF, Rand CM, Borch LA, et al.
Orphanet journal of rare diseases 2015; (10()):103 doi:10.1186/s13023-015-0314-x.
PMID: 26302956 - 11
Whole genome sequencing in ROHHAD trios proved inconclusive: what's beyond?
Grossi A, Rusmini M, Cusano R, et al.
Frontiers in genetics 2023; (14()):1031074 doi:10.3389/fgene.2023.1031074.
PMID: 37609037 - 12
ZSCAN1 Autoantibodies Are Associated with Pediatric Paraneoplastic ROHHAD.
Mandel-Brehm C, Benson LA, Tran B, et al.
Annals of neurology 2022; (92(2)):279-291 doi:10.1002/ana.26380.
PMID: 35466441 - 13
Antibodies Against ZSCAN1 in Pediatric and Adult Patients With Non-Paraneoplastic ROHHAD Syndrome.
Serafim AB, Olivé-Cirera G, Ortega-González Á, et al.
Neurology(R) neuroimmunology & neuroinflammation 2024; (11(5)):e200276 doi:10.1212/NXI.0000000000200276.
PMID: 38917381 - 14
ROHHAD syndrome and evolution of sleep disordered breathing.
Reppucci D, Hamilton J, Yeh EA, et al.
Orphanet journal of rare diseases 2016; (11(1)):106 doi:10.1186/s13023-016-0484-1.
PMID: 27473663
This page is for informational purposes only and does not constitute medical advice about your child’s ROHHAD symptoms or testing. Your child’s treating team should interpret findings and guide monitoring and care.